B-Type Natriuretic Peptide–Guided Heart Failure Therapy
نویسندگان
چکیده
منابع مشابه
B-type natriuretic peptide-guided treatment for heart failure
BACKGROUND Heart failure is a condition in which the heart does not pump enough blood to meet all the needs of the body. Symptoms of heart failure include breathlessness, fatigue and fluid retention. Outcomes for patients with heart failure are highly variable; however on average, these patients have a poor prognosis. Prognosis can be improved with early diagnosis and appropriate use of medical...
متن کاملB-type natriuretic peptide serum levels in acute heart failure.
We read with great interest the article by Cowie et al.1 on clinical applications of the assessment of B-type natriuretic peptide (BNP). This is an important subject and the article also helps to clarify which areas of BNP research need more attention. The authors conclude that in new patients presenting to emergency services with dyspnoea, if the BNP level is <100 pg/mL, then heart failure is ...
متن کاملClinical Significance of B-type Natriuretic Peptide in Heart Failure
Biochemical tests to detect B-type natriuretic peptide (BNP) or N-terminal pro-brain BNP (NT-proBNP) are useful diagnostic methods for patients with possible HF. These tests are valuable prognostic predictors for the entire spectrum of HF disease severity. Therefore, the measurements of BNP or NT-proBNP taken along with conventional clinical assessments may assist clinicians in deciding treatme...
متن کاملThe role of B-type natriuretic peptide in heart failure.
The use of BNP as a diagnostic and therapeutic tool in the management of heart failure is promising. Additional studies need to be done regarding the use of BNP as a diagnostic tool to clarify its intrapatient and interpatient variability, especially over time. Nesiritide is the first new intravenous agent for the treatment of acute decompensated heart failure since the introduction of milrinon...
متن کاملSubcutaneous B-type natriuretic peptide for treatment of heart failure: a dying therapy reborn?
Heart failure (HF) is among the leading causes of death and morbidity worldwide (2). The development of efficacious new therapies (such as angiotensin-converting enzyme inhibitors and beta-blockers) for HF has generally been tied to greater understanding of underlying pathophysiology. Therefore it is not surprising that the essential role played by natriuretic peptides in maintaining cardiac ho...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Internal Medicine
سال: 2010
ISSN: 0003-9926
DOI: 10.1001/archinternmed.2010.35